Pharma: Covid-19 R&D and Product Pipeline
We detail ongoing efforts by Pharma companies on Covid-19, going beyond vaccine development to cover those that are developing test kits and treatment drugs.
Read moreVanda Announces Positive Pivotal Study Results for HETLIOZ® (tasimelteon) in Patients with Smith-Magenis Syndrome
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that HETLIOZ® (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal placebo controlled clinical...
Read more